HS
VMD icon

HighVista Strategies’s Viemed Healthcare VMD Stock Holding History

HighVista Strategies’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,110
Closed -$78K – 117
2021
Q3 		$78K Buy
+14,110
New +$91.8K 0.05% 119

Other funds holding VMD

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

HighVista Strategies's VMD Position: Q4 2021 in Review

HighVista Strategies sold out of Viemed Healthcare (VMD) in Q4 2021, closing a stake of 14,110 shares — an estimated $78K sold.

HighVista Strategies first reported a position in VMD in Q3 2021 and held it in 1 quarter. The position peaked at $78K in Q3 2021. 88 funds tracked by Wall St. Rank hold VMD as of Q4 2021.

  • HighVista Strategies reported no remaining Viemed Healthcare position as of Q4 2021 after selling out during the quarter.
  • HighVista Strategies sold 14,110 Viemed Healthcare shares in Q4 2021, an estimated $78K.
  • HighVista Strategies first reported a position in Viemed Healthcare in Q3 2021 and held it in 1 quarter.
  • HighVista Strategies's Viemed Healthcare position peaked at $78K in Q3 2021.
  • 88 funds tracked by Wall St. Rank held Viemed Healthcare as of Q4 2021.

Based on HighVista Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.